- Home
- BABA vs ABBV Comparison
BABA vs ABBV Comparison
Compare BABA & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BABA
- ABBV
- Stock Information
- Founded
- BABA 1999
- ABBV 2012
- Country
- BABA China
- ABBV United States
- Employees
- BABA N/A
- ABBV N/A
- Industry
- BABA Business Services
- ABBV Biotechnology: Pharmaceutical Preparations
- Sector
- BABA Consumer Discretionary
- ABBV Health Care
- Exchange
- BABA Nasdaq
- ABBV Nasdaq
- Market Cap
- BABA 315.3B
- ABBV 370.7B
- IPO Year
- BABA 2014
- ABBV N/A
- Fundamental
- Price
- BABA $132.19
- ABBV $209.47
- Analyst Decision
- BABA Strong Buy
- ABBV Strong Buy
- Analyst Count
- BABA 14
- ABBV 21
- Target Price
- BABA $151.77
- ABBV $212.70
- AVG Volume (30 Days)
- BABA 22.5M
- ABBV 6.8M
- Earning Date
- BABA 05-13-2025
- ABBV 04-25-2025
- Dividend Yield
- BABA 0.74%
- ABBV 3.13%
- EPS Growth
- BABA 27.15
- ABBV N/A
- EPS
- BABA 6.75
- ABBV 2.39
- Revenue
- BABA $134,505,212,800.00
- ABBV $56,334,000,000.00
- Revenue This Year
- BABA $8.29
- ABBV $7.77
- Revenue Next Year
- BABA $7.27
- ABBV $8.14
- P/E Ratio
- BABA $19.61
- ABBV $87.65
- Revenue Growth
- BABA 5.85
- ABBV 3.71
- 52 Week Low
- BABA $68.36
- ABBV $153.58
- 52 Week High
- BABA $148.43
- ABBV $218.66
- Technical
- Relative Strength Index (RSI)
- BABA 49.94
- ABBV 56.67
- Support Level
- BABA $131.13
- ABBV $196.49
- Resistance Level
- BABA $137.79
- ABBV $215.50
- Average True Range (ATR)
- BABA 3.97
- ABBV 4.61
- MACD
- BABA -2.12
- ABBV -1.58
- Stochastic Oscillator
- BABA 15.99
- ABBV 68.28
About BABA Alibaba Group Holding Limited
Alibaba is the world's largest online and mobile commerce company as measured by gross merchandise volume. It operates China's online marketplaces, including Taobao (consumer-to-consumer) and Tmall (business-to-consumer). The China commerce retail division is the most valuable cash flow-generating business at Alibaba. Additional revenue sources include China commerce wholesale, international commerce retail/wholesale, local consumer services, cloud computing, digital media and entertainment platforms, Cainiao logistics services, and innovation initiatives/other.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).